Sugi Predict

Sugi Predict / Compounds / SCHEMBL17347124

SCHEMBL17347124

SCHEMBL17347124

O=C1[C@@H]2[C@H](C(=O)N1c1cc(Cl)cc(Cl)c1)[C@H]2c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ GAA P10253 3/20 0.48
▸ MAPT P10636 3/20 0.48
▸ ALOX15 P16050 2/20 0.48
▸ ALOX12 P18054 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.45
▸ ADCY2 Q08462 3/20 0.44
▸ ITGA4 P13612 1/20 0.43
▸ ITGB7 P26010 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ TSHR P16473 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22898500 1.00 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL17338881 1.00 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL17347068 1.00 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL18787456 1.00 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL17338998 0.83 ITGAL (0.42) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL17347061 0.83 ITGAL (0.42) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL17338997 0.83 ITGAL (0.42) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL17347096 0.83 ITGAL (0.42) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL17338995 0.83 ITGAL (0.42) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL18787390 0.83 ITGAL (0.42) ALDH1A1MEN1KMT2AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154941-B1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2021-01-20 — — EP disclosed
EP-3154941-B1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2021-01-20 — — EP disclosed
US-20190040008-A1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2019-02-07 — — US disclosed
US-10077238-B2 Small molecule LFA-1 inhibitors ALLOCYTE PHARMACEUTICALS AG (CH) 2018-09-18 — — US disclosed
US-20170121284-A1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2017-05-04 — — US disclosed
US-20170121284-A1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2017-05-04 — — US disclosed
US-20170121284-A1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2017-05-04 — — US disclosed
WO-2015189265-A1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2015-12-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10077238-B2 Small molecule LFA-1 inhibitors ICAM1, VCAM1, ITGB1 ALDH1A1 153/4885MEN1 3973/4885KMT2A 1882/4885
US-20190040008-A1 SMALL MOLECULE LFA-1 INHIBITORS ICAM1, VCAM1, ITGB1 ALDH1A1 153/4885MEN1 3973/4885KMT2A 1882/4885
US-20170121284-A1 SMALL MOLECULE LFA-1 INHIBITORS ICAM1, VCAM1, ITGB1 ALDH1A1 153/4885MEN1 3973/4885KMT2A 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.